Waters ALLIANCE IS BIO HPLC SYSTEM - Intuitive Simplicity for Biopharma

Importance of the topic

Biopharmaceutical QC laboratories increasingly face higher sample complexity, regulatory scrutiny, staff and time pressure, and the need to reduce analytical errors and rework. Robust, bioinert HPLC hardware and consumables that reduce non-specific adsorption of metal-sensitive analytes (e.g., oligonucleotides, phosphopeptides) are essential to deliver accurate, reproducible data, shorten time-to-result, and maintain compliance in routine testing and method transfers.

Objectives and overview of the brochure

This document presents the Waters Alliance iS Bio HPLC System featuring MaxPeak High Performance Surfaces (HPS) Technology. It aims to describe how system design, materials of construction, consumables and software tools improve bioseparations for proteins, peptides, oligonucleotides, mRNA, viral vectors and related modalities. Key claims illustrated include reduced non-specific adsorption, improved sensitivity and recovery, intuitive user experience to reduce errors, and streamlined method migration from legacy systems.

Methodology and approach

The brochure summarizes instrument development and application testing rather than providing full experimental protocols. Demonstrations compare the Alliance iS Bio System plus MaxPeak HPS‑enabled columns and vials against legacy HPLC configurations using representative assays: oligonucleotide RPLC/ion‑pairing separations, peptide RPLC, SEC for monoclonal antibodies, and method migration studies. Performance metrics reported include peak height, peak area, signal‑to‑noise, system suitability parameters and carryover. Emphasis is placed on minimizing analyte/surface interactions by combining corrosion‑resistant construction and surface treatments rather than altering mobile phase chemistry.

Used Instrumentation

The brochure highlights the following instrumentation and consumables:

• Alliance iS Bio HPLC System (Waters) with corrosion‑resistant materials and system status lighting
• MaxPeak High Performance Surfaces (HPS) Technology applied to system flowpaths and consumables
• MaxPeak Premier columns (bio‑inert variants) including XBridge Premier, XSelect Premier, BioResolve series, and MaxPeak Premier BEH/C4/C18 chemistries
• QuanRecovery (MaxPeak HPS) vials and plates; LCGC certified vials and polypropylene 300 µL vials
• eConnect NFC‑enabled HPLC columns
• Waters Empower software suite and Intelligent Method Translator App (iMTA)
• Supporting consumables and kits: PeptideWorks, OligoWorks SPE kits, GlycoWorks, IonHance buffers, RapiFluor‑MS kits

Main results and discussion

Key performance observations summarized from the brochure:

• Non‑specific adsorption (NSA) mitigation: MaxPeak HPS reduces interaction losses for electron‑rich analytes (phosphate/carboxylate groups), eliminating lengthy column/system passivation and improving analyte recovery and peak shape.
• Oligonucleotide separations: Compared to a legacy HPLC system, the Alliance iS Bio System with MaxPeak Premier BEH column produced approximately 30% higher peak height (better sensitivity) and ~15% higher peak area (improved recovery) in the example presented.
• Signal‑to‑noise gains: Method translation using the Intelligent Method Translator App (iMTA) combined with MaxPeak HPS consumables yielded up to ~40% increase in S/N for trace impurities in an oligonucleotide candidate (GEM91) example.
• mAb SEC and RP analyses: System suitability criteria for compendial mAb methods were met after migrating legacy methods; lower system dispersion yielded improved resolution for SEC separations.
• Peptide assays: For acidic peptides and phosphopeptides, the system improved retention time consistency, peak shape, and recovery under conventional RPLC conditions (0.1% formic acid mobile phases) versus legacy systems.
• Operational robustness and throughput: Tool‑free finger‑tight fittings tested for repeated reuse, low carryover, improved detector warm‑up and reduced drift, and redesigned check valves/mixers contribute to faster, reproducible workflows and fewer reruns.

Benefits and practical applications

The Alliance iS Bio HPLC System and MaxPeak HPS ecosystem offer practical advantages in QC and regulated workflows:

• Reduced rework and fewer failed runs through minimized NSA and pre‑run checks (touchscreen guided checks for vials, column identity and maintenance needs).
• Improved analytical sensitivity and recovery for metal‑sensitive modalities (oligonucleotides, phosphopeptides, some peptides), supporting trace impurity detection and accurate quantitation.
• Simplified method migration and digital traceability via iMTA, NFC‑enabled columns (eConnect), and Empower software—important for multi‑site and legacy method transfers.
• Compatibility with multi‑vendor columns eases transfer of established methods while providing options for bio‑inert MaxPeak Premier consumables where needed.
• Broad applicability across CQAs: aggregation (SEC), identity and subunit/intact analyses (RP), charge variants (IEX), glycan profiling (HILIC/mixed mode), and oligonucleotide/mRNA/AAV workflows.

Future trends and opportunities

Emerging directions suggested by the brochure and industry context:

• Wider adoption of bioinert flowpaths and surface technologies to support next‑generation modalities (mRNA, AAV, LNPs, oligonucleotides) and to reduce complex sample prep or mobile‑phase workarounds.
• Increased digitalization: NFC‑tagged consumables, automated method translation, and tighter LIMS/Chromatography Data System integration for faster, traceable method transfers and audit readiness.
• Standardization of vendor‑agnostic bioinert components to simplify cross‑platform method transfers and decrease validation burden in regulated environments.
• Greater focus on throughput and robustness in QC labs through improved fittings, reduced carryover, and preventative maintenance guidance embedded in instruments.

Conclusion

The Alliance iS Bio HPLC System with MaxPeak HPS Technology targets practical QC needs by addressing non‑specific adsorption of metal‑sensitive analytes, improving sensitivity, recovery and reproducibility while offering intuitive operation and digital tools for method migration and traceability. The integrated approach—hardware, consumables, and software—aims to reduce analysis variability and operational overhead, enabling more reliable bioseparations across proteins, peptides, oligonucleotides and viral or nucleic acid‑based modalities.

References

Waters Corporation. Alliance iS Bio HPLC System, product brochure. Milford, MA; 2024. April 24-12387 720008276EN Rev. A.